Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Endocrine. 2011 Oct;40(2):168-80. doi: 10.1007/s12020-011-9524-8. Epub 2011 Aug 26.
The process of homo- and/or heterodimerization of G-protein coupled receptors (GPCRs) and receptor tyrosine kinase (RTK) families are crucial for implicating the fundamental properties of receptor proteins including receptor expression, trafficking, and desensitization as well as signal transduction. The members of GPCR and RTK family constitute largest cell surface receptor proteins and regulate physiological functions of cells in response to external and internal stimuli. Notably, GPCRs and RTKs play major role in regulation of several key cellular functions which are associated with several pathological conditions including cancer biology, neurodegenerative and cardiovascular diseases. The focus of this review is to highlight the recent findings on the possible cross-talk between somatostatin receptors (members of GPCR family) and growth factor receptors like epidermal growth factor receptors (members of RTK family). Furthermore, functional consequences of such an interaction in modulation of signaling pathways linked to pathological conditions specifically in cancer are discussed.
G 蛋白偶联受体(GPCR)和受体酪氨酸激酶(RTK)家族的同源和/或异源二聚化过程对于涉及受体蛋白的基本特性至关重要,包括受体表达、运输和脱敏以及信号转导。GPCR 和 RTK 家族的成员构成了最大的细胞表面受体蛋白,并调节细胞对外部和内部刺激的生理功能。值得注意的是,GPCR 和 RTKs 在调节与几种病理状况相关的几种关键细胞功能方面发挥着主要作用,包括癌症生物学、神经退行性和心血管疾病。本篇综述的重点是强调生长抑素受体(GPCR 家族成员)与表皮生长因子受体(RTK 家族成员)等生长因子受体之间可能存在的串扰的最新发现。此外,还讨论了这种相互作用在调节与特定于癌症的病理状况相关的信号通路方面的功能后果。